13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND/OBJECTIVES

          Benign prostatic hypertrophy (BPH) is a major cause of abnormal overgrowth of the prostate mainly in the elderly. Corni Fructus has been reported to be effective in the prevention and treatment of various diseases because of its strong antioxidant effect, but its efficacy against BPH is not yet known. This study was designed to evaluate the therapeutic efficacy of Corni Fructus water extract (CF) in testosterone-induced BPH rats.

          MATERIALS/METHODS

          To induce BPH, rats were intraperitoneal injected with testosterone propionate (TP). Rats in the treatment group were orally administered with CF with TP injection, and finasteride, which is a selective inhibitor of 5α-reductase type 2, was used as a positive control.

          RESULTS

          Our results showed that the increased prostate weight and histopathological changes in BPH model rats were suppressed by CF treatment. CF, similar to the finasteride-treated group, decreased the levels of testosterone and dihydrotestosterone by TP treatment in the serum, and it also reduced 5α-reductase expression and concentration in prostate tissue and serum, respectively. In addition, CF significantly blocked the expression of the androgen receptor (AR), AR co-activators, and proliferating cell nuclear antigen in BPH rats, and this blocking was associated with a decrease in prostate-specific antigen levels in serum and prostate tissue.

          CONCLUSIONS

          These results suggest that CF may weaken the BPH status through the inactivation of at least 5α-reductase and AR activity and may be useful for the clinical treatment of BPH.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

          Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common clinical problems in urology. While the precise molecular etiology remains unclear, sex steroids have been implicated in the development and maintenance of BPH. Sufficient data exists linking androgens and androgen receptor pathways to BPH and use of androgen reducing compounds, such as 5α-reductase inhibitors which block the conversion of testosterone into dihydrotestosterone, are a component of the standard of care for men with LUTS attributed to an enlarged prostate. However, BPH is a multifactorial disease and not all men respond well to currently available treatments, suggesting factors other than androgens are involved. Testosterone, the primary circulating androgen in men, can also be metabolized via CYP19/aromatase into the potent estrogen, estradiol-17β. The prostate is an estrogen target tissue and estrogens directly and indirectly affect growth and differentiation of prostate. The precise role of endogenous and exogenous estrogens in directly affecting prostate growth and differentiation in the context of BPH is an understudied area. Estrogens and selective estrogen receptor modulators (SERMs) have been shown to promote or inhibit prostate proliferation signifying potential roles in BPH. Recent research has demonstrated that estrogen receptor signaling pathways may be important in the development and maintenance of BPH and LUTS; however, new models are needed to genetically dissect estrogen regulated molecular mechanisms involved in BPH. More work is needed to identify estrogens and associated signaling pathways in BPH in order to target BPH with dietary and therapeutic SERMs. Published by Elsevier B.V.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Correlation between benign prostatic hyperplasia and inflammation.

            This review aims to evaluate the available evidence on the role of prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). Although there is still no evidence of a causal relation, accumulating evidence suggests that inflammation may contribute to the development of BPH and lower urinary tract symptoms (LUTS). Inflammatory infiltrates are frequently observed in prostate tissue specimens from men with BPH and the presence or degree of inflammation has been found to be correlated with prostate volume and weight. The inflammatory injury may contribute to cytokine production by inflammatory cells driving local growth factor production and angiogenesis in the prostatic tissue. This proinflammatory microenvironment is closely related to BPH stromal hyperproliferation and tissue remodeling with a local hypoxia induced by increased oxygen demands by proliferating cells which supports chronic inflammation as a source of oxidative stress leading to tissue injury in infiltrating area. Although the pathogenesis of BPH is not yet fully understood and several mechanisms seem to be involved in the development and progression, recent studies strongly suggest that BPH is an immune inflammatory disease. The T-cell activity and associated autoimmune reaction seem to induce epithelial and stromal cell proliferation. Further understanding of the role of inflammation in BPH and clinical detection of this inflammation will expand the understanding of BPH pathogenesis and its histologic and clinical progression, allow risk stratification for patients presenting with BPH-related LUTS, and suggest novel treatment strategies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Ethnopharmacology, phytochemistry, and pharmacology of Cornus officinalis Sieb. et Zucc.

              Cornus officinalis (Cornaceae), known in Chinese as "Shanzhuyu," is a frequently used traditional Chinese medicine. It tastes sour and is astringent and slightly warm in nature. Its fruits have long been used to treat kidney deficiency, high blood pressure, waist and knee pain, dizziness, tinnitus, impotence, spermatorrhea, menorrhagia, and other diseases in China. The main distribution areas are Shanxi and Gansu.
                Bookmark

                Author and article information

                Journal
                Nutr Res Pract
                Nutr Res Pract
                NRP
                Nutrition Research and Practice
                The Korean Nutrition Society and the Korean Society of Community Nutrition
                1976-1457
                2005-6168
                October 2018
                23 July 2018
                : 12
                : 5
                : 378-386
                Affiliations
                [1 ]Anti-Aging Research Center, Dongeui University, Busan 47340, Korea.
                [2 ]Open Laboratory for Muscular and Skeletal Disease and Department of Biochemistry, Dongeui University College of Korean Medicine, 42 San, Yangjungdong, Busan 47227, Korea.
                [3 ]Department of Anatomy, Kosin University College of Medicine, Busan 49267, Korea.
                [4 ]Gurye Sansooyu Farming Association Corporation, Jeonnam 57602, Korea.
                [5 ]Gurye-gun Agricultural Center, Jeonnam 57660, Korea.
                [6 ]Department of Anatomy, Dongeui University College of Korean Medicine, Busan 47227, Korea.
                [7 ]Laboratory of Immunobiology, Department of Marine Life Sciences, Jeju National University, Jeju 63243, Korea.
                [8 ]Department of Molecular Biology, College of Natural Sciences, Dongeui University, Busan 47340, Korea.
                Author notes
                Corresponding Author: Yung Hyun Choi, Tel. 82-51-850-7413, Fax. 82-51-853-4036, choiyh@ 123456deu.ac.kr
                Author information
                https://orcid.org/0000-0003-2180-1205
                https://orcid.org/0000-0001-5492-7184
                https://orcid.org/0000-0002-9141-4596
                https://orcid.org/0000-0001-9083-8218
                https://orcid.org/0000-0003-3827-4173
                https://orcid.org/0000-0001-8564-8663
                https://orcid.org/0000-0002-3149-4723
                https://orcid.org/0000-0002-5089-3439
                https://orcid.org/0000-0003-3237-6662
                https://orcid.org/0000-0002-3175-7204
                https://orcid.org/0000-0002-6878-0790
                https://orcid.org/0000-0001-9291-5803
                https://orcid.org/0000-0003-4906-0410
                https://orcid.org/0000-0001-6982-7389
                https://orcid.org/0000-0002-1454-3124
                Article
                10.4162/nrp.2018.12.5.378
                6172175
                4a5f628b-8040-4390-ba89-15e0a84277e0
                ©2018 The Korean Nutrition Society and the Korean Society of Community Nutrition

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 05 February 2018
                : 27 February 2018
                : 19 June 2018
                Funding
                Funded by: Ministry of Agriculture, Food and Rural Affairs, CrossRef https://doi.org/10.13039/501100003624;
                Award ID: G0090200-09
                Funded by: Korea Food Research Institute, CrossRef https://doi.org/10.13039/501100003712;
                Funded by: National Research Foundation of Korea, CrossRef https://doi.org/10.13039/501100003725;
                Award ID: 2018R1A2B2005705
                Categories
                Original Research

                Nutrition & Dietetics
                benign prostatic hyperplasia,corni fructus,dihydrotestosterone,androgen receptor,prostate-specific antigen

                Comments

                Comment on this article